• Connect with us
    • Information
      • About Us
      • Contact Us
      • Careers
      • Partnerships
      • Advertise With Us
      • Authors
      • Browse Topics
      • Events
      • Disclaimer
      • Privacy Policy
    • Australia
      North America
      World
    Login
    Investing News NetworkYour trusted source for investing success
    • North America
      Australia
      World
    • My INN
    Videos
    Companies
    Press Releases
    Private Placements
    SUBSCRIBE
    • Reports & Guides
      • Market Outlook Reports
      • Investing Guides
    • Button
    Resource
    • Precious Metals
    • Battery Metals
    • Base Metals
    • Energy
    • Critical Metals
    Tech
    Life Science
    Biotech Market
    Biotech News
    Biotech Stocks
    • Biotech Market
    • Biotech News
    • Biotech Stocks

    Electrophysiology Devices Market to Grow at a CAGR of 5.0% From 2014 to 2020: Grand View Research, Inc.

    Investing News Network
    Mar. 29, 2016 09:15AM PST
    Biotech Investing

    Electrophysiology devices industry is anticipated to grow at a CAGR of over 5.0% and reach over USD 6.18 billion by 2020 owing to growing old age population and frequent cardiac arrhythmias incidents.

    SAN FRANCISCO, CA–(Marketwired – Mar 29, 2016) – Electrophysiology devices industry is anticipated to grow at a CAGR of over 5.0% and reach over USD 6.18 billion by 2020 owing to growing old age population and frequent cardiac arrhythmias incidents. Adoption of ablation and diagnostics techniques among physicians has resulted in increased usage of the product in the past few years and is likley to drive market growth. Development of new devices such as nanostimleadless pacemaker is also anticipated to fuel demand in the market.
    Catherer ablation has gained popularity as the first line treatment, rendering 95.0% success rate for several rhythm disorders and is anticipated to be a key driving factor for growth. Diagnostic electrophysiology catheters are estimated to grow at the CAGR of over 15.0% in the foreseeable future. Technological developments such as laser ablation, cryo-ablation and ultrasound ablation, coupled with optimised mapping techniques are anticipated to augment market growth over the forecast period.
    Browse full research report with TOC on “Electrophysiology Devices Market Analysis By Application (Cardiac Resynchronization Therapy, Holter Monitoring Devices, Electroretinograph, Electrocardiograph, Diagnostic Electrophysiology Catheters, Imaging and 3D Mapping Systems, Electroencephalograph, Electromyograph, X-Ray, Electrocorticograph, Electrooculograph, Pacemakers, Implantable Cardioverter Defibrillators) And Segment Forecasts To 2020” at: https://www.grandviewresearch.com/industry-analysis/electrophysiology-devices-market
    Electrophysiology treatment & monitoring devices contributed to a share of over 60.0% of in 2013. X-ray systems were the most widely used device in electrophysiology monitoring sector. Market growth can be attributed to improving diagnostic interventional capabilities of healthcare consultants and increasing usage of digital and portable systems. Technological improvements such as Optima IGS 320 and GE Healthcare’s Innova IGS 520 are projected to provide future opportunities for growth. These are dose efficient products and interventional X-ray systems that allow physicians to perform compound interventional procedures with accuracy and ease.
    Electrophysiology treatment devices include pacemakers, implantable cardioverter defibrillators (ICD) and catheters. Catheters emerged as the largest treatment devices segment in 2013 owing to growing number of interventional procedures and extensive usage of treatment devices in electrophysiology readings. However, rising costs related with the product, existence of strict regulations and accessibility of substitute therapies are anticipated to hamper growth over the forecast period.
    In 2013, North America contributed to over 30.0% of the overall market share and emerged as the dominant market owing to frequent occurrence of cardiac arrhythmia resulting from unhealthy lifestyle habits. Increasing demand for the latest healthcare infrastructure and rising consumer awareness are anticipated to propel growth.
    Asia-Pacific is a lucrative market owing to high rate of unmet medical requirements leading to increase in the number of patients. Rapid developments in healthcare infrastructure and increase in disposable income in emerging economies such as India and China are expected to provide new avenues and opportunities for companies to capitalize over the forecast period.
    Key electrophysiology device manufacturers include Biotronik SE & Co. KG, Medtronic Inc., St. Jude Medical, Boston Scientific Corporation and Abbott Laboratories.
     Browse related reports by Grand View Research:
    About Grand View Research
    Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
    Read Our Blogs – Ni2014.org, grandviewresearch.blog

    ge healthcarechinaboston scientificindia
    The Conversation (0)

    Go Deeper

    AI Powered
    Surgeons stand around a hospital bed with patient on it and a surgical robot above it.

    8 Surgical Robotics Stocks

    Stethoscope connected to a phone with medical data overlay.

    Top 5 Small-cap Medical Device Stocks (Updated January 2025)

    Latest News

    SVN-SDN-14 PTSD Programme - Positive pre-clinical results with three high-performing candidates advancing to in vivo studies

    Cardiol Therapeutics to Participate in Fireside Chat at Canaccord Genuity's 45th Annual Growth Conference

    More News

    Outlook Reports

    Resource
    • Precious Metals
      • Gold
      • Silver
    • Battery Metals
      • Lithium
      • Cobalt
      • Graphite
    • Energy
      • Uranium
      • Oil and Gas
    • Base Metals
      • Copper
      • Nickel
      • Zinc
    • Critical Metals
      • Rare Earths
    • Industrial Metals
    • Agriculture
    Tech
      • Artificial Intelligence
      • Cybersecurity
      • Gaming
      • Cleantech
      • Emerging Tech
    Life Science
      • Biotech
      • Cannabis
      • Psychedelics
      • Pharmaceuticals

    Featured Biotech Investing Stocks

    More featured stocks

    Browse Companies

    Resource
    • Precious Metals
    • Battery Metals
    • Energy
    • Base Metals
    • Critical Metals
    Tech
    Life Science
    MARKETS
    COMMODITIES
    CURRENCIES
    ×